Work

What have we learnt from the rosiglitazone saga?

Year: 2011

Type: editorial

Source: BMJ

DOI: 10.1136/bmj.d1354

Authors: V. M. Montori, N. D. Shah

Institution: Mayo Clinic

Language: English

Topic: Pharmacovigilance and Adverse Drug Reactions

Subfield: Toxicology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2006561359

Cites: 10

Cited by: 11

Related to: 10